Advancements in technology, data analytics, genomics, and personalized medicine have significantly impacted the road to new medicines. These advancements have accelerated the drug discovery process, enabled targeted therapies, and facilitated the development of precision medicines tailored to specific patient populations. In summary, the road to new medicines is a complex and dynamic process that involves target identification, hit identification, preclinical development, clinical trials, regulatory approval, post-marketing surveillance, and continuous research and innovation. R&D advancements have transformed the landscape of pharmaceutical development, allowing for the discovery and development of innovative therapies that improve patient outcomes and address unmet medical needs.